Fundraising Fox

Simbiosys

Chicago, US · Founded 2018 · Delaware corporation · 3 known investors

simbiosys.com ↗

Simbiosys develops AI-powered 3D visualization and diagnostic technology that converts 2D medical imaging into interactive 3D digital tumor models to support surgical planning and patient treatment. The platform serves surgeons and oncologists in breast cancer and other oncology settings.

AI & Machine LearningBiotechDigital HealthMedical Devicesin /simbiosys-inc@simbiosys

Founders & leadership

JP
Joseph PetersonExecutive Officer, Director
SSStacey Stevens
Stacey StevensExecutive Officer, Director
JA
John A ColeExecutive Officer
VCVikram Chaudhery
Vikram ChaudheryDirector
LCLucy Coassin
Lucy CoassinDirector
RARonnie Andrews
Ronnie AndrewsDirector
WHWilliam Hyun
William HyunDirector

Investors · 3

AV8 VenturesPalo Alto · $500K – $10M
Genoa VenturesSan Francisco
GENERAL INCEPTIONreportedPalo Altovia Vikram Chaudhery · board

Reported raises · per SEC filings

Form D private placements
▶$5.2MraisedJan 2025 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lucy CoassinDirector
  • Vikram ChaudheryDirector
  • Ronnie AndrewsDirector
  • William HyunDirector
  • Joseph PetersonExecutive Officer, Director
  • Stacey StevensExecutive Officer, Director
Offering amount
$8M
Amount sold
$5.2M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$900KraisedNov 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John A ColeExecutive Officer
  • Joseph R PetersonExecutive Officer
Offering amount
$1.3M
Amount sold
$900K
Minimum investment
$50K
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.